Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Interaction of Immune and Cancer Cells (eBook)

eBook Download: PDF
2022 | 2nd ed. 2022
XIV, 350 Seiten
Springer International Publishing (Verlag)
978-3-030-91311-3 (ISBN)

Lese- und Medienproben

Interaction of Immune and Cancer Cells -
Systemvoraussetzungen
181,89 inkl. MwSt
(CHF 177,70)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

Now, it its second edition, this book summarizes the role of immune cells in tumor suppression and progression. It describes in detail why tumor cells can survive and spread in spite of the antitumor response of immune cells.

Since immunotherapy is an attractive approach to cancer therapy, this book also provides information on the two main strategies: monoclonal antibodies and adaptive T cell immunotherapy, with a focus on recent human clinical trials. A newly added chapter also focuses on the role of Natural Killer cells in tumor progression.

The book provides a state-of-the-art, comprehensive overview of immune cells in cancer and is an indispensable resource for researchers and practitioners working or lecturing in the field of cancer research and immunology.




Magdalena Klink received her PhD in Immunology at the University of Lodz, Poland, in 1994. She was Senior Research Assistant at the Microbiology and Virology Center of the Polish Academy of Sciences, Lodz, Poland and Post-doctoral researcher at the Department of Immunology, College of Natural Sciences, Chungnam National University, Taejon, Republic of Korea. Since 2004 she has been working at the Institute of Medical Biology of the Polish Academy of Sciences in Lodz, Poland. In 2005 she completed her post-doctoral studies in Immunology (Habilitation). Since 2016 she is a Team Leader of the Molecular and Cellular Biology Lab at above Institute and since 2017 she is a full Professor. She was the Principal Investigators of several grants from national sources. She received awards for research including the Rector of the University of Lodz, the Minister of Education, The Scientific Committee of Conference and the Director of the Institute for Medical Biology, PAS. She was a supervisor of a few doctoral thesis. She has been serving as the Associate Editor of the journal Mediators of Inflammation (2007-2017 and as the Scientific Editor for Current Awareness Bulletin for Novartis Pharma AG company (2005-2008). She was a lecturer in the Academy of Cosmetics and Healthcare, Warsaw Poland (2014-2018).

Izabela Szulc-Kielbik received her microbiology MSc in 2010 at the Faculty of Biology and Environmental Protection, University of Lodz. After graduation she has started working as research assistant in the Institute of Medical Biology at the Polish Academy of Sciences in Lodz, Poland, where she was preparing her doctoral thesis. In 2015 she received her PhD degree with distinction in the medical biology specialization. Since 2016 she is a member of the Molecular and Cellular Biology Lab at the Institute of Medical Biology. Izabela has authored more than 15 scientific publications and she was a main investigator or co-investigator in 4 different projects, one international and three granted by national sources. She was awarded for her research on a few national and international conferences and by the Director of the Institute of Medical Biology.

Erscheint lt. Verlag 14.2.2022
Reihe/Serie Experientia Supplementum
Experientia Supplementum
Zusatzinfo XIV, 350 p. 22 illus., 20 illus. in color.
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Studium Querschnittsbereiche Infektiologie / Immunologie
Schlagworte Cancer Therapy • cancer vaccines • immune system • Immunoediting • Immunosurveillance • natural killer cells • Polymorphonuclear neutrophils • tumor-associated macrophages • Tumor-infiltrating lymphocytes • tumor microenvironment • tumor progression • Tumor–stroma interaction • Tumour vaccines
ISBN-10 3-030-91311-2 / 3030913112
ISBN-13 978-3-030-91311-3 / 9783030913113
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 7,2 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Antibiotika, Virostatika, Antimykotika, Antiparasitäre Wirkstoffe

von Hans-Reinhard Brodt; Achim Hörauf; Michael Kresken …

eBook Download (2023)
Thieme (Verlag)
CHF 159,95